Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer
Figure 1
The EGFR Signaling Pathway. (a) Upon EGF-ligand binding to the EGFR there is subsequent
dimerization (homo- or hetero-) and
tyrosine kinase residue auto-/transphosphorylation of dimer partners, which in
turn initiates the actual downstream signaling pathways. (b) Ras signaling cascade in tabulated form. (c) PI3K signaling cascade in
tabulated form.